Volume 9 Issue 4 - International Pharmaceutical Industry

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Volume 9 Issue 4

Rethinking the Cold Supply Chain

Healthcare manufacturers should continually look for ways to optimise their cold-chain packaging. In her article, Susan Li of UPS shows that the benefits of doing so...

4 January 2018 Volume 9 Issue 4 chain | cold

Continue Reading →

Volume 9 Issue 4

What Clinical Teams Should Know about Changing Trial Logistics and How they will Affect Development – PART 2

As we shift to what has been described as “an Amazonlike culture”, sponsors want the same opportunity to track shipments in real time and to obtain real-time data th...

4 January 2018 Volume 9 Issue 4 affect | changing

Continue Reading →

Volume 9 Issue 4

Strategies for Developing a Cost-Efficient Pharmaceutical Manufacturing Process

In their paper, Valdas Jurkauskas and Xiaoyong Fu of STA Pharmaceuticals address the fact that manufacturing process throughput optimisation has become a necessity r...

4 January 2018 Volume 9 Issue 4 cost | developing

Continue Reading →

Volume 9 Issue 4

Inspecting on the Edge – Understanding Punch Tip Wear

Punch tip edge wear can come from a variety of circumstances and may cause significant production quality-related issues. In their article, Bill Turner and Kevin Que...

4 January 2018 Volume 9 Issue 4 edge | inspecting

Continue Reading →

Volume 9 Issue 4

What Does the Falsified Medicines Directive (FMD) Mean for SMEs and CMOs; and More Importantly, Are These Organisations Ready?

The implications of the directive are far-reaching and affect all pharmaceutical manufacturers, regardless of size. As time runs out and the deadline grows ever clos...

4 January 2018 Volume 9 Issue 4 directive | falsified

Continue Reading →

Volume 9 Issue 4

Designing Smart Integrated Drug Delivery Systems

Wearable drug delivery technology is a good example of how drug delivery technology providers continue to stay ahead of the curve. In his piece, Graham Reynolds of G...

4 January 2018 Volume 9 Issue 4 delivery | designing

Continue Reading →

Volume 9 Issue 4

Why Anti-microbial Protection Remains Crucial in Fight Against Infection

Strands of potential superbugs are developing all the time, and everything must be done to ensure they don’t become a topic of hot – and daunting – conversation once...

4 January 2018 Volume 9 Issue 4 infection | microbial

Continue Reading →

Volume 9 Issue 4

Serialisation: The Current Conversation

Serialisation remains the hot topic across the pharmaceutical industry, and will continue to be so with the deadlines for compliance fast approaching in both the US ...

4 January 2018 Volume 9 Issue 4

Continue Reading →

Volume 9 Issue 4

From Seller to Navigator: The Changing Role of the Sales Rep

While the role of the sales rep is certainly changing, the industry shift towards intelligent engagement means it may prove more valuable than ever. In this article,...

4 January 2018 Volume 9 Issue 4

Continue Reading →